Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with ...

SRINAGAR: In a major breakthrough, the doctors at GMC Rajouri have administered atropine to treat 11 patients who fell ill from a mysterious illness in Badhal village of J&K’s Rajouri.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...

The EMA’s Committee for Medicinal Products for Human Use said that a phase 3 study in children aged 3-14 years demonstrated ...

Sydnexis, Inc. ( a pre-commercial stage biopharmaceutical company, today announced that the European Medicines Agency’s (EMA) ...

Diphenoxylate HCl 2.5mg, atropine sulfate 0.025mg; per 5mL liq; alcohol 15%. See full labeling. <2yrs: not recommended. 2–12yrs: initially 0.3–0.4mg/kg in 4 divided doses until diarrhea is ...

Suggested remit: To appraise the clinical and cost effectiveness of low-dose atropine eye drops within its marketing authorisation for treating myopia in people 3 to 14 years.